Skip to main content
. 2019 Feb 4;49(6):2281–2290. doi: 10.1007/s10803-018-03871-4

Table 1.

Gothenburg and Stockholm samples: background factors

Variables Gbg (n = 96)a Stk (n = 207)b Statistic p
Male (F (%)) 79 (82.3) 175 (84.5) 0.245c 0.621
Age at T1-years (M (SD)) 3.0 (0.53) 3.8 (0.68) -11.165d < 0.001
Age at T2-years (M (SD)) 5.2 (0.53) 5.5 (0.73) -3.364d 0.001
Parents have different ethnicity (F (%)) 22 (23.2) 44 (21.4) 0.123c 0.726
Any NDD in first degree relative? (F (%)) 48 (50.0) 71 (34.29) 6.779c 0.009
Number siblings (M (SD)) 1.62 (0.96) 1.14 (0.81) 4.40d < 0.001
Birth order (M (SD)) 2.09 (0.96) 1.63 (0.77) 1.399d < 0.001
Any maternal disease in pregnancy? (F (%))e 30 (31.3) 87 (48.6) 7.698c 0.006
Gestational age (M (SD)) 39.2 (2.50) 39.1 (2.16) 0.367d 0.714
Born at term (37–41 weeks)? (F (%)) 69 (71.9) 178 (86.0) 8.735c 0.013
Caesarean section? (F (%)) 17 (17.7) 59 (29.2) 4.529c 0.033
Neonatal care? (F (%)) 20 (20.8) 39 (20.0) 0.028c 0.868
Age walking (M (SD)) 13.8 (2.92) 14.5 (4.69) − 1.575d 0.116
Toe walking? (F (%)) 28 (29.2) 70 (33.7) 0.648c 0.421
Feeding problems first 2 years? (F (%)) 46 (47.9) 38 (18.4) 28.599c < 0.001

Significant p values (p < .01) are highlighted in bold

NDD: Neurodevelopmental Disorder

aSpecific N for each variable ranged from 88 to 96

bSpecific N for each variable ranged from 179 to 207

cchi-squared test

dt-test

eGbg data from single variable; Stk data compiled from more detailed data: chronic condition, acute condition, and/or pharmacological intervention in pregnancy